Development Level

Tdark 56 | 6,593
Tbio 42 | 11,651
Tchem 6 | 1,388
Tclin 4 | 612

IMPC Phenotype

decreased mean corpuscular vol... 2 | 79
increased circulating sodium l... 2 | 71
preweaning lethality, incomple... 2 | 499
abnormal kidney morphology 1 | 65
abnormal seminal vesicle morph... 1 | 114
cardiovascular system phenotyp... 1 | 36
decreased bone mineral content 1 | 151
decreased circulating glucose ... 1 | 126
decreased grip strength 1 | 116
decreased lymphocyte cell numb... 1 | 83
decreased prepulse inhibition 1 | 82
decreased red blood cell distr... 1 | 41
hypoactivity 1 | 132
increased aggression 1 | 4
increased erythrocyte cell num... 1 | 39
increased hematocrit 1 | 46
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 96
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
polycystic kidney 1 | 15
shortened RR interval 1 | 17
thrombocytopenia 1 | 56
tremors 1 | 39

Disease

Carcinoma 35 | 11,493
lung cancer 30 | 4,740
ovarian cancer 28 | 8,520
non-small cell lung cancer 27 | 2,890
lung adenocarcinoma 25 | 2,716
interstitial cystitis 24 | 2,312
lung carcinoma 24 | 2,843
psoriasis 23 | 6,694
Autosomal recessive predisposition 21 | 1,442
pancreatic ductal adenocarcinoma liver metastasis 21 | 1,962
ulcerative colitis 21 | 1,819
osteosarcoma 19 | 7,950
glioblastoma 17 | 5,792
intraductal papillary-mucinous adenoma (IPMA) 16 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 16 | 2,989
invasive ductal carcinoma 16 | 2,951
tuberculosis 16 | 2,010
malignant mesothelioma 15 | 3,232
Astrocytoma, Pilocytic 14 | 3,081
Cancer 14 | 2,499
intraductal papillary-mucinous neoplasm (IPMN) 14 | 3,291
periodontitis 14 | 293
Age related macular degeneration 13 | 72
Kidney disease 13 | 430
subependymal giant cell astrocytoma 13 | 2,287
Complement deficiency 12 | 14
pancreatic cancer 12 | 2,398
adrenocortical carcinoma 11 | 1,428
Duchenne muscular dystrophy 10 | 601
Hemolytic-Uremic Syndrome 10 | 30
Immunologic Deficiency Syndromes 10 | 113
Meningitis 10 | 67
Systemic lupus erythematosus 10 | 194
chronic lymphosyte leukemia 10 | 204
dermatomyositis 10 | 966
juvenile dermatomyositis 10 | 1,187
medulloblastoma, large-cell 10 | 6,241
primary Sjogren syndrome 10 | 735
Anemia 9 | 365
Melanoma 9 | 711
Multiple myeloma 9 | 1,332
Rheumatoid arthritis 9 | 1,191
acute quadriplegic myopathy 9 | 1,158
colon cancer 9 | 1,478
cystic fibrosis 9 | 1,696
ependymoma 9 | 4,679
limb girdle muscular dystrophy 2A 9 | 213
mucosa-associated lymphoid tissue lymphoma 9 | 484
Kidney cancer 8 | 2,613
Lupus Erythematosus, Systemic 8 | 67
Skin cancer 8 | 469
atypical teratoid / rhabdoid tumor 8 | 5,112
esophageal adenocarcinoma 8 | 737
nasopharyngeal carcinoma 8 | 1,058
pituitary cancer 8 | 1,972
Breast cancer 7 | 3,578
Liver Cirrhosis, Experimental 7 | 769
Schizophrenia 7 | 1,160
Vascular disease 7 | 319
astrocytoma 7 | 1,146
autosomal dominant Emery-Dreifuss muscular dystrophy 7 | 510
cutaneous lupus erythematosus 7 | 1,057
diabetes mellitus 7 | 1,728
group 3 medulloblastoma 7 | 4,104
Arthritis 6 | 290
Atypical Hemolytic Uremic Syndrome 6 | 9
Autoimmune Diseases 6 | 67
Becker muscular dystrophy 6 | 191
Lupus erythematosus 6 | 57
Macular degeneration 6 | 65
Purpura 6 | 43
Thrombocytopenia 6 | 197
adult high grade glioma 6 | 3,801
breast carcinoma 6 | 1,638
gastric carcinoma 6 | 807
primary pancreatic ductal adenocarcinoma 6 | 1,109
Angioedema 5 | 38
Atopic dermatitis 5 | 952
Down syndrome 5 | 499
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 5 | 7
Increased susceptibility to bacterial infections 5 | 42
Lymphoma 5 | 81
Multiple Sclerosis 5 | 540
Prone to bacterial infection 5 | 42
Recurrent bacterial infection 5 | 42
active ulcerative colitis 5 | 764
chronic kidney disease 5 | 90
cystic fibrosis and chronic rhinosinusitis 5 | 214
head and neck cancer and chronic obstructive pulmonary disease 5 | 239
oligodendroglioma 5 | 2,850
sonic hedgehog group medulloblastoma 5 | 467
Atherosclerosis 4 | 291
Diarrhea 4 | 253
Glomerulonephritis, IGA 4 | 34
IGA Glomerulonephritis 4 | 50
Liver Cirrhosis 4 | 181
Pneumonia 4 | 174
active Crohn's disease 4 | 922
astrocytic glioma 4 | 2,597
hepatocellular carcinoma 4 | 547

Tissue

Liver and Pancreas 46 | 16,750
Urinary Tract 46 | 16,678
Endocrine System 44 | 18,159
Blood and immune system 40 | 16,909
Digestive Tract 40 | 17,369
Male tissues 40 | 17,142
Skin and soft tissues 40 | 17,230
Female tissues 39 | 17,400
Respiratory system 39 | 16,393
Cardiovascular System 35 | 15,192
Nervous System 35 | 16,725

Target Family

Non-IDG 99 | 12,091
Enzyme 5 | 4,145
GPCR 3 | 408
Transcription Factor 1 | 1,400

GO Process

regulation of complement activ... 108 | 108
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C4b-binding protein alpha chain C4BPA Tbio Non-IDG -2.43425 244.7 172
Complement component C9 C9 Tbio Non-IDG -1.88910 74.6 285
Complement C1q subcomponent subunit C C1QC Tbio Non-IDG -1.31972 17.9 168
Complement C1q subcomponent subunit B C1QB Tbio Non-IDG -1.66860 42.5 189
B-lymphocyte antigen CD19 CD19 Tclin Non-IDG -3.54335 3206.2 2794
Complement C5 C5 Tclin Non-IDG -2.26690 170.8 448
Complement C3 C3 Tbio Non-IDG -3.55963 3446.1 1079
Carboxypeptidase N catalytic chain CPN1 Tchem Enzyme -2.71738 529.1 145
Properdin CFP Tbio Non-IDG -3.18478 1522.9 371
Complement decay-accelerating factor CD55 Tbio Non-IDG -3.05523 1115.2 1004